NASDAQ:TYRA | Free Cash Flow | Tyra Biosciences, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$32.57M$88,000.00-$32.66M
2025-12-31-$23.62M$57,000.00-$23.68M
2025-03-31-$25.46M$14,000.00-$25.47M
2024-12-31-$19.59M$6,000.00-$19.6M
2024-03-31-$22.03M$136,000.00-$22.16M
2023-12-31-$13.53M$603,000.00-$14.14M
2023-03-31-$9.85M$41,000.00-$9.89M
2022-12-31-$11.98M$21,000.00-$12M
2022-03-31-$8.93M$239,000.00-$9.16M
2021-12-31-$9.03M$105,000.00-$9.13M
2021-03-31-$4.68M$60,000.00-$4.74M
2020-12-31-$2.53M$67,000.00-$2.6M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$95.14M$141,000.00-$95.28M
2024-12-31-$69.77M$664,000.00-$70.44M
2023-12-31-$50.14M$770,000.00-$50.91M
2022-12-31-$50.29M$559,000.00-$50.84M
2021-12-31-$23.75M$661,000.00-$24.41M
2020-12-31-$7.76M$312,000.00-$8.08M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.